C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/24 (2006.01) C07K 16/28 (2006.01) C07K 16/46 (2006.01)
Patent
CA 2753287
The invention relates to combinations of RANKL antagonists with TNF-alpha antagonists and provides antigen-binding constructs which bind to RANKL comprising a protein scaffold which are linked to one or more epitope-binding domains wherein the antigen-binding construct has at least two antigen binding sites at least one of which is from an epitope binding domain and at least one of which is from a paired VH/VL domain, methods of making such constructs and uses thereof.
L'invention concerne des combinaisons d'antagonistes de RANKL avec des antagonistes de TNF-alpha et concerne des constructions de liaison d'antigène qui se lient à RANKL comprenant un échafaudage protéique qui sont liées à un ou plusieurs domaines de liaison d'épitope où la construction de liaison d'antigène a au moins deux sites de liaison d'antigène dont au moins un est d'un domaine de liaison d'épitope et dont au moins un est d'un domaine VH/VL apparié, des procédés de préparation de telles constructions et des utilisations de celles-ci.
Hamblin Paul Andrew
Parmar Radha Shah
White John
Glaxo Group Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Antigen-binding constructs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen-binding constructs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen-binding constructs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1629714